Repligen (RGEN) Net Equity Issued and Repurchased (2019 - 2023)
Repligen (RGEN) posted quarterly Net Equity Issued and Repurchased of -$10000.0 for Q3 2023, down 100.01% quarter-over-quarter from $131.1 million in Q3 2019.
Repligen (RGEN) Net Equity Issued and Repurchased (2019 - 2023) Analysis & Trends
Repligen (RGEN) has reported Net Equity Issued and Repurchased for 2 consecutive years, with -$10000.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Net Equity Issued and Repurchased changed N/A year-over-year to -$10000.0; the TTM figure through Sep 2023 stood at -$10000.0 (down 100.01% YoY), while the FY2020 annual figure was $297.8 million, down 7.15% from the prior year.
- Net Equity Issued and Repurchased eased to -$10000.0 in Q3 2023 per RGEN's latest filing, from $131.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $131.1 million in Q3 2019 and bottomed at -$10000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 29.31 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2019 | 131.09 Mn |
| Sep 30, 2019 | 131.09 Mn |